{"transactions":[{"id":684633,"issuer":{"id":1449,"kind":"organization","name":"TERADATA CORP /DE/","symbol":"TDC"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-18T21:31:54.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":2197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of restricted share units issued under the Director Compensation Program. The units vest in four equal quarterly installments commencing three months after the grant date."}],"balance_after":86091,"source":{"system":"sec-edgar","filing":"0001577243-26-000004","document":"wk-form4_1787088712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816761/000157724326000004/wk-form4_1787088712.xml","form_type":"4"}},{"id":776065,"issuer":{"id":1449,"kind":"organization","name":"TERADATA CORP /DE/","symbol":"TDC"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:17:55.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":8790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of restricted share units issued under the Director Compensation Program. The units vest in four equal quarterly installments commencing three months after the grant date."}],"balance_after":83894,"source":{"system":"sec-edgar","filing":"0001577243-26-000002","document":"wk-form4_1779135472.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816761/000157724326000002/wk-form4_1779135472.xml","form_type":"4"}},{"id":794768,"issuer":{"id":3856,"kind":"organization","name":"SELECTIVE INSURANCE GROUP INC","symbol":"SIGI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-04T20:03:00.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":1767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The award of 1,767 restricted stock units will vest on May 1, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7.47140 dividend equivalent units.  Each dividend equivalent unit is the economic equivalent of one share of Selective Insurance Group, Inc. common stock."}],"balance_after":8552.1324,"source":{"system":"sec-edgar","filing":"0001225208-26-004812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/230557/000122520826004812/doc4.xml","form_type":"4"}},{"id":796740,"issuer":{"id":5002,"kind":"organization","name":"DOUGLAS DYNAMICS, INC"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-30T20:40:49.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":2737,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20242,"source":{"system":"sec-edgar","filing":"0000897069-26-000985","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287213/000089706926000985/form4.xml","form_type":"4"}},{"id":923690,"issuer":{"id":3856,"kind":"organization","name":"SELECTIVE INSURANCE GROUP INC","symbol":"SIGI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-02-03T21:07:24.000Z","date":"2026-02-02","kind":"purchase","planned":false,"acquired":true,"shares":600,"price":84.81,"value":50886.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 21.00780 dividend equivalent units.  Each dividend equivalent unit is the economic equivalent of one share of Selective Insurance Group, Inc. common stock."}],"balance_after":6777.661,"source":{"system":"sec-edgar","filing":"0001225208-26-001155","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/230557/000122520826001155/doc4.xml","form_type":"4"}},{"id":1144111,"issuer":{"id":1449,"kind":"organization","name":"TERADATA CORP /DE/","symbol":"TDC"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T20:44:04.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":11489,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of restricted share units issued under the Director Compensation Program. The units vest in four equal quarterly installments commencing three months after the grant date."}],"balance_after":75104,"source":{"system":"sec-edgar","filing":"0000816761-25-000145","document":"wk-form4_1747687437.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816761/000081676125000145/wk-form4_1747687437.xml","form_type":"4"}},{"id":1160299,"issuer":{"id":3856,"kind":"organization","name":"SELECTIVE INSURANCE GROUP INC","symbol":"SIGI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-05T20:01:48.000Z","date":"2025-05-02","kind":"grant","planned":false,"acquired":true,"shares":1666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes the award of 1,426 restricted stock units that will vest on May 2, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 18.18590 dividend equivalent units.  Each dividend equivalent unit is the economic equivalent of one share of Selective Insurance Group, Inc. common stock."}],"balance_after":6156.6532,"source":{"system":"sec-edgar","filing":"0001225208-25-004652","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/230557/000122520825004652/doc4.xml","form_type":"4"}},{"id":1259355,"issuer":{"id":5002,"kind":"organization","name":"DOUGLAS DYNAMICS, INC"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-02-19T22:18:50.000Z","date":"2025-02-18","kind":"grant","planned":false,"acquired":true,"shares":4394,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17505,"source":{"system":"sec-edgar","filing":"0000897069-25-000327","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287213/000089706925000327/form4.xml","form_type":"4"}},{"id":1516677,"issuer":{"id":1449,"kind":"organization","name":"TERADATA CORP /DE/","symbol":"TDC"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-15T23:34:26.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":6927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of restricted share units issued under the Director Compensation Program. The units vest in four equal, quarterly installments commencing three months after the grant date."}],"balance_after":63615,"source":{"system":"sec-edgar","filing":"0000816761-24-000114","document":"wk-form4_1715816047.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816761/000081676124000114/wk-form4_1715816047.xml","form_type":"4"}},{"id":1526969,"issuer":{"id":3856,"kind":"organization","name":"SELECTIVE INSURANCE GROUP INC","symbol":"SIGI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-06T20:19:44.000Z","date":"2024-05-03","kind":"grant","planned":false,"acquired":true,"shares":1141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The award of 1,141 restricted stock units will vest on May 3, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 13.7970 dividend equivalent units.  Each dividend equivalent unit is the economic equivalent of one share of Selective Insurance Group, Inc. common stock."}],"balance_after":4472.4673,"source":{"system":"sec-edgar","filing":"0001225208-24-005661","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/230557/000122520824005661/doc4.xml","form_type":"4"}},{"id":1642874,"issuer":{"id":5002,"kind":"organization","name":"DOUGLAS DYNAMICS, INC"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-14T23:04:12.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":4142,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13111,"source":{"system":"sec-edgar","filing":"0000897069-24-000391","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287213/000089706924000391/form4.xml","form_type":"4"}},{"id":1895886,"issuer":{"id":1449,"kind":"organization","name":"TERADATA CORP /DE/","symbol":"TDC"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-12T16:17:29.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":6176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Award of restricted share units issued under the Director Compensation Program. The units vest in four equal, quarterly installments commencing three months after the grant date."}],"balance_after":56688,"source":{"system":"sec-edgar","filing":"0001209191-23-028922","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816761/000120919123028922/doc4.xml","form_type":"4"}},{"id":1901756,"issuer":{"id":3856,"kind":"organization","name":"SELECTIVE INSURANCE GROUP INC","symbol":"SIGI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-08T20:15:57.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":1065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The award of 1,065 restricted stock units will vest on May 5, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15.6053 dividend equivalent units.  Each dividend equivalent unit is the economic equivalent of one share of Selective Insurance Group, Inc. common stock."}],"balance_after":3317.6703,"source":{"system":"sec-edgar","filing":"0001225208-23-005571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/230557/000122520823005571/doc4.xml","form_type":"4"}},{"id":2010751,"issuer":{"id":5002,"kind":"organization","name":"DOUGLAS DYNAMICS, INC"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-16T22:19:46.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":2820,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8969,"source":{"system":"sec-edgar","filing":"0001567619-23-003193","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287213/000156761923003193/doc1.xml","form_type":"4"}},{"id":2274145,"issuer":{"id":1449,"kind":"organization","name":"TERADATA CORP /DE/","symbol":"TDC"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-12T21:02:11.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":5828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Award of restricted share units issued under the Director Compensation Program. The units vest in four equal, quarterly installments commencing three months after the grant date."}],"balance_after":50512,"source":{"system":"sec-edgar","filing":"0001209191-22-028588","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816761/000120919122028588/doc4.xml","form_type":"4"}},{"id":2278592,"issuer":{"id":3856,"kind":"organization","name":"SELECTIVE INSURANCE GROUP INC","symbol":"SIGI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-09T21:59:26.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":1172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The award of 1,172 restricted stock units will vest on May 6, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 14.0650 dividend equivalent units.  Each dividend equivalent unit is the economic equivalent of one share of Selective Insurance Group, Inc. common stock."}],"balance_after":2237.065,"source":{"system":"sec-edgar","filing":"0001225208-22-006735","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/230557/000122520822006735/doc4.xml","form_type":"4"}},{"id":2388077,"issuer":{"id":5002,"kind":"organization","name":"DOUGLAS DYNAMICS, INC"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-17T21:54:39.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":2951,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6149,"source":{"system":"sec-edgar","filing":"0001567619-22-004895","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287213/000156761922004895/doc1.xml","form_type":"4"}},{"id":2725699,"issuer":{"id":1449,"kind":"organization","name":"TERADATA CORP /DE/","symbol":"TDC"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-06T21:42:54.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":5657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Award of restricted share units issued under the Director Compensation Program. The units vest in four equal, quarterly installments commencing three months after the grant date."}],"balance_after":44684,"source":{"system":"sec-edgar","filing":"0001209191-21-030677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816761/000120919121030677/doc4.xml","form_type":"4"}},{"id":2733778,"issuer":{"id":3856,"kind":"organization","name":"SELECTIVE INSURANCE GROUP INC","symbol":"SIGI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-03T20:07:21.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":1051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The award of 1,051 restricted stock units will vest on April 30, 2022."}],"balance_after":1051,"source":{"system":"sec-edgar","filing":"0001225208-21-007370","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/230557/000122520821007370/doc4.xml","form_type":"4"}},{"id":2849525,"issuer":{"id":5002,"kind":"organization","name":"DOUGLAS DYNAMICS, INC"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-18T15:23:32.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":2282,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3198,"source":{"system":"sec-edgar","filing":"0001567619-21-004375","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287213/000156761921004375/doc1.xml","form_type":"4"}},{"id":2998014,"issuer":{"id":5002,"kind":"organization","name":"DOUGLAS DYNAMICS, INC"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-29T22:25:34.000Z","date":"2020-10-28","kind":"grant","acquired":true,"shares":916,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":916,"source":{"system":"sec-edgar","filing":"0001567619-20-018343","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287213/000156761920018343/doc1.xml","form_type":"4"}},{"id":3158751,"issuer":{"id":1449,"kind":"organization","name":"TERADATA CORP /DE/","symbol":"TDC"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-07T20:52:46.000Z","date":"2020-05-05","kind":"grant","acquired":true,"shares":10913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Award of restricted share units issued under the Director Compensation Program. The units vest in four equal, quarterly installments commencing three months after the grant date."}],"balance_after":39027,"source":{"system":"sec-edgar","filing":"0001209191-20-027734","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816761/000120919120027734/doc4.xml","form_type":"4"}},{"id":3543272,"issuer":{"id":1449,"kind":"organization","name":"TERADATA CORP /DE/","symbol":"TDC"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-02T22:13:19.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":5628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Award of restricted share units issued under the Director Compensation Program. The units vest in four equal, quarterly installments commencing three months after the grant date."}],"balance_after":28114,"source":{"system":"sec-edgar","filing":"0001209191-19-027090","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816761/000120919119027090/doc4.xml","form_type":"4"}},{"id":3594414,"issuer":{"id":1449,"kind":"organization","name":"TERADATA CORP /DE/","symbol":"TDC"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-15T21:21:26.000Z","date":"2019-03-14","kind":"sale","acquired":false,"shares":12000,"price":48.038,"value":576456.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.98 to $48.13. The reporting person has provided to the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":22486,"source":{"system":"sec-edgar","filing":"0001209191-19-019763","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816761/000120919119019763/doc4.xml","form_type":"4"}},{"id":3613326,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chief Marketing Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-03-06T02:24:08.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":836,"price":177.85,"value":148682.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax obligations upon vesting."}],"balance_after":24024,"source":{"system":"sec-edgar","filing":"0001225208-19-004745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004745/doc4.xml","form_type":"4"}},{"id":3613325,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chief Marketing Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-03-06T02:24:08.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":2624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2016-2018 three-year performance period.  The number of shares of common stock received was based upon actual performance against pre-established Company performance goals."}],"balance_after":24860,"source":{"system":"sec-edgar","filing":"0001225208-19-004745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004745/doc4.xml","form_type":"4"}},{"id":3623389,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-02T01:22:13.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":3578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in three equal annual installments beginning February 27, 2020."}],"balance_after":3578,"derivative":{"exercise_price":183.4405,"exercise_date":"2020-02-27","expiration_date":"2029-02-27","underlying":"Common Stock, $.01 Par Value","underlying_shares":3578},"source":{"system":"sec-edgar","filing":"0001225208-19-004241","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004241/doc4.xml","form_type":"4"}},{"id":3623388,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chief Marketing Officer"}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-03-02T01:22:13.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":1036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted shares vest in three equal annual installments beginning February 27, 2020."}],"balance_after":22236,"source":{"system":"sec-edgar","filing":"0001225208-19-004241","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004241/doc4.xml","form_type":"4"}},{"id":3719155,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Mktg Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:11:55.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":5844,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option, which would have vested in three equal installments beginning on February 28, 2019, was assumed by New Cigna in the Merger and converted into an option to purchase an equal number of shares of New Cigna Common Stock for $197.35 per share on the same vesting terms."}],"balance_after":5844,"derivative":{"exercise_price":197.35,"expiration_date":"2028-02-28","underlying":"Common Stock, $0.01 Par Value","underlying_shares":5844},"source":{"system":"sec-edgar","filing":"0001567619-18-008693","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008693/doc1.xml","form_type":"4"}},{"id":3719154,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Mktg Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:11:55.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":7711,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One-third of this option was vested at the time of the Merger. The option was assumed by New Cigna in the Merger and converted into an option to purchase an equal number of shares of New Cigna Common Stock for $149.135 per share, with the remaining two-thirds of the option vesting in two equal installments on February 28, 2019 and February 28, 2020."}],"balance_after":7711,"derivative":{"exercise_price":149.135,"expiration_date":"2027-02-28","underlying":"Common Stock, $0.01 Par Value","underlying_shares":7711},"source":{"system":"sec-edgar","filing":"0001567619-18-008693","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008693/doc1.xml","form_type":"4"}},{"id":3719153,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Mktg Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:11:55.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":5673,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Two-thirds of this option was vested at the time of the Merger. The option was assumed by New Cigna in the Merger and converted into an option to purchase an equal number of shares of New Cigna Common Stock for $139.22 per share, with the remaining one-third of the option vesting on March 1, 2019."}],"balance_after":5673,"derivative":{"exercise_price":139.22,"expiration_date":"2026-03-01","underlying":"Common Stock, $0.01 Par Value","underlying_shares":5673},"source":{"system":"sec-edgar","filing":"0001567619-18-008693","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008693/doc1.xml","form_type":"4"}},{"id":3719152,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Mktg Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:11:55.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":3126,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":3126,"derivative":{"exercise_price":120.895,"expiration_date":"2025-02-25","underlying":"Common Stock, $0.01 Par Value","underlying_shares":3126},"source":{"system":"sec-edgar","filing":"0001567619-18-008693","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008693/doc1.xml","form_type":"4"}},{"id":3719151,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Mktg Officer"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2018-12-27T00:11:55.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":21200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."}],"balance_after":21200,"source":{"system":"sec-edgar","filing":"0001567619-18-008693","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008693/doc1.xml","form_type":"4"}},{"id":3720304,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chf Marketing & Cust Off"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-26T18:41:07.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":5844,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option, which would have vested in three equal installments beginning on February 28, 2019, was assumed by New Cigna in the Merger and converted into an option to purchase an equal number of shares of New Cigna Common Stock for $197.35 per share on the same vesting terms."}],"balance_after":0,"derivative":{"exercise_price":197.35,"expiration_date":"2028-02-28","underlying":"Common Stock, $.25 Par Value","underlying_shares":5844},"source":{"system":"sec-edgar","filing":"0001567619-18-008648","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/701221/000156761918008648/doc1.xml","form_type":"4"}},{"id":3720303,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chf Marketing & Cust Off"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-26T18:41:07.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":7711,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One-third of this option was vested at the time of the Merger. The option was assumed by New Cigna in the Merger and converted into an option to purchase an equal number of shares of New Cigna Common Stock for $149.135 per share, with the remaining two-thirds of the option vesting in two equal installments on February 28, 2019 and February 28, 2020."}],"balance_after":0,"derivative":{"exercise_price":149.135,"expiration_date":"2027-02-28","underlying":"Common Stock, $.25 Par Value","underlying_shares":7711},"source":{"system":"sec-edgar","filing":"0001567619-18-008648","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/701221/000156761918008648/doc1.xml","form_type":"4"}},{"id":3720302,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chf Marketing & Cust Off"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-26T18:41:07.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":5673,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Two-thirds of this option was vested at the time of the Merger. The option was assumed by New Cigna in the Merger and converted into an option to purchase an equal number of shares of New Cigna Common Stock for $139.22 per share, with the remaining one-third of the option vesting on March 1, 2019."}],"balance_after":0,"derivative":{"exercise_price":139.22,"expiration_date":"2026-03-01","underlying":"Common Stock, $.25 Par Value","underlying_shares":5673},"source":{"system":"sec-edgar","filing":"0001567619-18-008648","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/701221/000156761918008648/doc1.xml","form_type":"4"}},{"id":3720301,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chf Marketing & Cust Off"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-26T18:41:07.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":3126,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":120.895,"expiration_date":"2025-02-25","underlying":"Common Stock, $.25 Par Value","underlying_shares":3126},"source":{"system":"sec-edgar","filing":"0001567619-18-008648","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/701221/000156761918008648/doc1.xml","form_type":"4"}},{"id":3720300,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chf Marketing & Cust Off"}}],"security":"Common Stock, $.25 Par Value","published_at":"2018-12-26T18:41:07.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":21200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-18-008648","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701221/000156761918008648/doc1.xml","form_type":"4"}},{"id":3960435,"issuer":{"id":1449,"kind":"organization","name":"TERADATA CORP /DE/","symbol":"TDC"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-19T20:22:50.000Z","date":"2018-04-17","kind":"grant","acquired":true,"shares":6216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Award of restricted share units issued under the Director Compensation Program. The units vest in four equal, quarterly installments commencing three months after the grant date."}],"balance_after":34486,"source":{"system":"sec-edgar","filing":"0001209191-18-025557","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816761/000120919118025557/doc4.xml","form_type":"4"}},{"id":4012914,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chf Marketing & Cust Off"}}],"security":"Common Stock, $.25 Par Value","published_at":"2018-03-06T18:40:59.000Z","date":"2018-03-02","kind":"tax_withholding","acquired":false,"shares":1248,"price":192.44,"value":240165.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax obligations upon vesting."}],"balance_after":21200,"source":{"system":"sec-edgar","filing":"0001225208-18-005493","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520818005493/doc4.xml","form_type":"4"}},{"id":4012913,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chf Marketing & Cust Off"}}],"security":"Common Stock, $.25 Par Value","published_at":"2018-03-06T18:40:59.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":3947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2015-2017 three-year performance period.  The number of shares of common stock received was based upon actual performance against pre-established Company performance goals."}],"balance_after":22448,"source":{"system":"sec-edgar","filing":"0001225208-18-005493","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520818005493/doc4.xml","form_type":"4"}},{"id":4022431,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chf Marketing & Cust Off"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-02T17:26:10.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":5844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in three equal annual installments beginning February 28, 2019."}],"balance_after":5844,"derivative":{"exercise_price":197.35,"exercise_date":"2019-02-28","expiration_date":"2028-02-28","underlying":"Common Stock, $.25 Par Value","underlying_shares":5844},"source":{"system":"sec-edgar","filing":"0001225208-18-005174","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520818005174/doc4.xml","form_type":"4"}},{"id":4231738,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chf Marketing & Cust Off"}}],"security":"Common Stock, $.25 Par Value","published_at":"2017-08-17T17:11:36.000Z","date":"2017-08-16","kind":"sale","acquired":false,"shares":2236,"price":179.949,"value":402365.964,"ownership":{"direct":true},"balance_after":18501,"source":{"system":"sec-edgar","filing":"0001225208-17-014140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817014140/doc4.xml","form_type":"4"}},{"id":4304074,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chf Marketing & Cust Off"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-05-26T16:14:05.000Z","date":"2017-05-24","kind":"exercise","acquired":false,"shares":2836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in three equal annual installments.  The first installment became exercisable on March 1, 2017, and the next two installments become exercisable on March 1, 2018 and March 1, 2019."}],"balance_after":5673,"derivative":{"exercise_price":139.22,"exercise_date":"2017-03-01","expiration_date":"2026-03-01","underlying":"Common Stock, $.25 Par Value","underlying_shares":2836},"source":{"system":"sec-edgar","filing":"0001225208-17-010488","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817010488/doc4.xml","form_type":"4"}},{"id":4304073,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chf Marketing & Cust Off"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-05-26T16:14:05.000Z","date":"2017-05-24","kind":"exercise","acquired":false,"shares":4603,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on February 26, 2014.  The option vested in three equal annual installments on the first, second and third anniversaries of the grant date."}],"balance_after":0,"derivative":{"exercise_price":78.035,"exercise_date":"2015-02-26","expiration_date":"2024-02-26","underlying":"Common Stock, $.25 Par Value","underlying_shares":4603},"source":{"system":"sec-edgar","filing":"0001225208-17-010488","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817010488/doc4.xml","form_type":"4"}},{"id":4304072,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chf Marketing & Cust Off"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-05-26T16:14:05.000Z","date":"2017-05-24","kind":"exercise","acquired":false,"shares":6252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in three equal annual installments.  The first installment became exercisable on February 25, 2016, the second installment became exercisable on February 25, 2017, and the last installment becomes exercisable on February 25, 2018."}],"balance_after":3126,"derivative":{"exercise_price":120.895,"exercise_date":"2016-02-25","expiration_date":"2025-02-25","underlying":"Common Stock, $.25 Par Value","underlying_shares":6252},"source":{"system":"sec-edgar","filing":"0001225208-17-010488","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817010488/doc4.xml","form_type":"4"}},{"id":4304071,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chf Marketing & Cust Off"}}],"security":"Common Stock, $.25 Par Value","published_at":"2017-05-26T16:14:05.000Z","date":"2017-05-24","kind":"sale","acquired":false,"shares":11455,"price":161.5686,"value":1850768.313,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average price of the shares sold.  The prices actually received ranged from $161.5607 to $161.60 per share.  The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":20737,"source":{"system":"sec-edgar","filing":"0001225208-17-010488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817010488/doc4.xml","form_type":"4"}},{"id":4304070,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chf Marketing & Cust Off"}}],"security":"Common Stock, $.25 Par Value","published_at":"2017-05-26T16:14:05.000Z","date":"2017-05-24","kind":"exercise","acquired":true,"shares":2836,"price":139.22,"value":394827.92,"ownership":{"direct":true},"balance_after":32192,"source":{"system":"sec-edgar","filing":"0001225208-17-010488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817010488/doc4.xml","form_type":"4"}},{"id":4304069,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chf Marketing & Cust Off"}}],"security":"Common Stock, $.25 Par Value","published_at":"2017-05-26T16:14:05.000Z","date":"2017-05-24","kind":"exercise","acquired":true,"shares":4603,"price":78.035,"value":359195.105,"ownership":{"direct":true},"balance_after":29356,"source":{"system":"sec-edgar","filing":"0001225208-17-010488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817010488/doc4.xml","form_type":"4"}},{"id":4304068,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chf Marketing & Cust Off"}}],"security":"Common Stock, $.25 Par Value","published_at":"2017-05-26T16:14:05.000Z","date":"2017-05-24","kind":"exercise","acquired":true,"shares":6252,"price":120.895,"value":755835.54,"ownership":{"direct":true},"balance_after":24753,"source":{"system":"sec-edgar","filing":"0001225208-17-010488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817010488/doc4.xml","form_type":"4"}},{"id":4349094,"issuer":{"id":1449,"kind":"organization","name":"TERADATA CORP /DE/","symbol":"TDC"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-20T19:59:12.000Z","date":"2017-04-19","kind":"grant","acquired":true,"shares":8183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Award of restricted share units issued under the Director Compensation Program. The units vest in four equal, quarterly installments commencing three months after the grant date."}],"balance_after":28270,"source":{"system":"sec-edgar","filing":"0001209191-17-027670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816761/000120919117027670/doc4.xml","form_type":"4"}},{"id":4412175,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chf Marketing & Cust Off"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-03-02T17:48:37.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":7711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in three equal annual installments beginning February 28, 2018."}],"balance_after":7711,"derivative":{"exercise_price":149.135,"exercise_date":"2018-02-28","expiration_date":"2027-02-28","underlying":"Common Stock, $.25 Par Value","underlying_shares":7711},"source":{"system":"sec-edgar","filing":"0001225208-17-005398","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817005398/doc4.xml","form_type":"4"}},{"id":4419864,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chf Marketing & Cust Off"}}],"security":"Common Stock, $.25 Par Value","published_at":"2017-02-28T18:47:06.000Z","date":"2017-02-24","kind":"tax_withholding","acquired":false,"shares":1784,"price":147.08,"value":262390.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax obligations upon vesting."}],"balance_after":18501,"source":{"system":"sec-edgar","filing":"0001225208-17-004973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817004973/doc4.xml","form_type":"4"}},{"id":4419863,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chf Marketing & Cust Off"}}],"security":"Common Stock, $.25 Par Value","published_at":"2017-02-28T18:47:06.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":5144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2014-2016 three-year performance period.  The number of shares of common stock received was based upon actual performance against pre-established Company performance goals."}],"balance_after":20285,"source":{"system":"sec-edgar","filing":"0001225208-17-004973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817004973/doc4.xml","form_type":"4"}},{"id":4551714,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2016-11-17T17:37:57.000Z","date":"2016-11-15","kind":"exercise","acquired":false,"shares":11331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on May 20, 2013.  The option vested in three equal annual installments on the first, second and third anniversaries of the grant date."}],"balance_after":0,"derivative":{"exercise_price":67.33,"exercise_date":"2014-05-20","expiration_date":"2023-05-20","underlying":"Common Stock, $.25 Par Value","underlying_shares":11331},"source":{"system":"sec-edgar","filing":"0001225208-16-041940","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520816041940/doc4.xml","form_type":"4"}},{"id":4551713,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2016-11-17T17:37:57.000Z","date":"2016-11-15","kind":"exercise","acquired":false,"shares":9207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on February 26, 2014.  The option vests in three equal annual installments on the first, second and third anniversaries of the grant date."}],"balance_after":4603,"derivative":{"exercise_price":78.035,"exercise_date":"2015-02-26","expiration_date":"2024-02-26","underlying":"Common Stock, $.25 Par Value","underlying_shares":9207},"source":{"system":"sec-edgar","filing":"0001225208-16-041940","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520816041940/doc4.xml","form_type":"4"}},{"id":4551712,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chief Marketing Officer"}}],"security":"Common Stock, $.25 Par Value","published_at":"2016-11-17T17:37:57.000Z","date":"2016-11-15","kind":"sale","acquired":false,"shares":15548,"price":137.6924,"value":2140841.4352,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average price of the shares sold.  The prices actually received ranged from $137.5898 to $137.84 per share.  The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":15141,"source":{"system":"sec-edgar","filing":"0001225208-16-041940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520816041940/doc4.xml","form_type":"4"}},{"id":4551711,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chief Marketing Officer"}}],"security":"Common Stock, $.25 Par Value","published_at":"2016-11-17T17:37:57.000Z","date":"2016-11-15","kind":"exercise","acquired":true,"shares":9207,"price":78.035,"value":718468.245,"ownership":{"direct":true},"balance_after":30689,"source":{"system":"sec-edgar","filing":"0001225208-16-041940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520816041940/doc4.xml","form_type":"4"}},{"id":4551710,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":22581,"kind":"person","name":"Bacus Lisa R","position":1,"cik":"0001577243","reported_name":"Bacus Lisa R","relationship":{"officer":true,"officer_title":"EVP, Chief Marketing Officer"}}],"security":"Common Stock, $.25 Par Value","published_at":"2016-11-17T17:37:57.000Z","date":"2016-11-15","kind":"exercise","acquired":true,"shares":11331,"price":67.33,"value":762916.23,"ownership":{"direct":true},"balance_after":21482,"source":{"system":"sec-edgar","filing":"0001225208-16-041940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520816041940/doc4.xml","form_type":"4"}}]}